PharmaResearch Co Ltd
KOSDAQ:214450
Intrinsic Value
PharmaResearch Co., Ltd. engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology. [ Read More ]
The intrinsic value of one PharmaResearch Co Ltd stock under the Base Case scenario is hidden KRW. Compared to the current market price of 137 300 KRW, PharmaResearch Co Ltd is hidden .
Valuation Backtest
PharmaResearch Co Ltd
Run backtest to discover the historical profit from buying and selling PharmaResearch Co Ltd stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Balance Sheet Decomposition
PharmaResearch Co Ltd
| Current Assets | 256.5B |
| Cash & Short-Term Investments | 160.3B |
| Receivables | 36.3B |
| Other Current Assets | 59.8B |
| Non-Current Assets | 278.8B |
| Long-Term Investments | 112.8B |
| PP&E | 123.1B |
| Intangibles | 32B |
| Other Non-Current Assets | 11B |
| Current Liabilities | 65.9B |
| Accounts Payable | 2.8B |
| Accrued Liabilities | 974.3m |
| Short-Term Debt | 400m |
| Other Current Liabilities | 61.7B |
| Non-Current Liabilities | 36.3B |
| Long-Term Debt | 1.3B |
| Other Non-Current Liabilities | 35B |
Earnings Waterfall
PharmaResearch Co Ltd
|
Revenue
|
261B
KRW
|
|
Cost of Revenue
|
-70.8B
KRW
|
|
Gross Profit
|
190.3B
KRW
|
|
Operating Expenses
|
-98B
KRW
|
|
Operating Income
|
92.3B
KRW
|
|
Other Expenses
|
-15.7B
KRW
|
|
Net Income
|
76.6B
KRW
|
Free Cash Flow Analysis
PharmaResearch Co Ltd
Profitability Score
Profitability Due Diligence
PharmaResearch Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Score
PharmaResearch Co Ltd's profitability score is hidden . The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
PharmaResearch Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Score
PharmaResearch Co Ltd's solvency score is hidden . The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
PharmaResearch Co Ltd
According to Wall Street analysts, the average 1-year price target for PharmaResearch Co Ltd is 172 550 KRW with a low forecast of 151 500 KRW and a high forecast of 199 500 KRW.
Shareholder Return
Price
PharmaResearch Co Ltd
| Average Annual Return | 17.88% |
| Standard Deviation of Annual Returns | 41.6% |
| Max Drawdown | -42% |
| Market Capitalization | 1.4T KRW |
| Shares Outstanding | 10 239 148 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Country
Industry
Market Cap
Dividend Yield
Description
PharmaResearch Co., Ltd. engages in the research and development of refined raw materials for cell and tissue regeneration through marine bio technology. The company is headquartered in Gangneung, Gangwon-Do. The company went IPO on 2015-07-24. The firm produces and sells regenerated products such as pharmaceuticals, medical devices, and cosmetics. In addition, the Company is involved in the venture investment and real estate leasing. The firm mainly provides its products in domestic market.
Contact
IPO
Employees
Officers
The intrinsic value of one PharmaResearch Co Ltd stock under the Base Case scenario is hidden KRW.
Compared to the current market price of 137 300 KRW, PharmaResearch Co Ltd is hidden .
You don't have any saved screeners yet
